Philadelphia, Pennsylvania (PA) In Vitro and In Vivo Diagnostic Substances Companies

Featured companies
Genzyme Corporation
833 Chestnut St Ste 1250
Philadelphia PA 19107
Avid Radiopharmaceuticals Inc
3711 Market St Floor 7
Philadelphia PA 19104
(215) 298-0700
Bray Paul F MD
1015 Walnut St # 115
Philadelphia PA 19107
(215) 955-6969
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Erythrometrics LLC
774 North Union St.
Philadelphia PA 19104
(215) 630-3675
Integrated Genetics
833 Chestnut St # 1250
Philadelphia PA 19107
(215) 351-2331
Qlida Diagnostics Inc
3711 Market St.
Philadelphia PA 19104
(609) 510-7667
Invisible Sentinel Inc.
3711 Market Street, 8th Floor
Philadelphia PA 191045504
(215) 296-6500

At Invisible Sentinel, we develop next generation technologies for a safer food supply.
Limitless Longevity
1601 Walnut St # 810
Philadelphia PA 19102
(215) 279-8376
The International Society Of Neurovirology
Merb Room 740
Philadelphia PA 19140
(215) 707-9788
The Hope Center
716 North Broad St.
Philadelphia PA 19130
(267) 546-3600
Whereorg has 12 results under In Vitro and In Vivo Diagnostic Substances Companies in Philadelphia.

Narrow down the browsing criteria below to see more companies.

Select a location for category In Vitro and In Vivo Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020